Annual CFI
$129.83 M
+$434.62 M+142.60%
31 December 2023
Summary:
Biohaven Pharmaceutical Holding annual cash flow from investing activities is currently $129.83 million, with the most recent change of +$434.62 million (+142.60%) on 31 December 2023. During the last 3 years, it has risen by +$132.53 million (+4913.87%). BHVN annual CFI is now at all-time high.BHVN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$93.40 M
+$4.53 M+4.63%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding quarterly cash flow from investing activities is currently -$93.40 million, with the most recent change of +$4.53 million (+4.63%) on 30 September 2024. Over the past year, it has dropped by -$151.95 million (-259.52%). BHVN quarterly CFI is now -222.48% below its all-time high of $76.25 million, reached on 30 June 2023.BHVN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$161.21 M
-$151.95 M-1640.01%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding TTM cash flow from investing activities is currently -$161.21 million, with the most recent change of -$151.95 million (-1640.01%) on 30 September 2024. Over the past year, it has dropped by -$30.94 million (-23.75%). BHVN TTM CFI is now -197.75% below its all-time high of $164.92 million, reached on 31 March 2024.BHVN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BHVN Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +142.6% | -259.5% | -23.8% |
| 3 y3 years | +4913.9% | - | - |
| 5 y5 years | +1331.8% | -4250.2% | -4160.4% |
BHVN Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +142.6% | -222.5% | +64.6% | -197.8% | +47.3% |
| 5 y | 5 years | at high | +142.6% | -222.5% | +64.6% | -197.8% | +47.3% |
| alltime | all time | at high | +142.6% | -222.5% | +64.6% | -197.8% | +47.3% |
Biohaven Pharmaceutical Holding Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$93.40 M(-4.6%) | -$161.21 M(+1640.0%) |
| June 2024 | - | -$97.93 M(-387.8%) | -$9.27 M(-105.6%) |
| Mar 2024 | - | $34.03 M(-969.5%) | $164.92 M(+27.0%) |
| Dec 2023 | $129.83 M(-142.6%) | -$3.91 M(-106.7%) | $129.83 M(-199.7%) |
| Sept 2023 | - | $58.55 M(-23.2%) | -$130.27 M(-32.6%) |
| June 2023 | - | $76.25 M(-7300.6%) | -$193.34 M(-36.7%) |
| Mar 2023 | - | -$1.06 M(-99.6%) | -$305.60 M(+0.3%) |
| Dec 2022 | -$304.79 M(<-9900.0%) | -$264.02 M(+5735.9%) | -$304.79 M(+647.5%) |
| Sept 2022 | - | -$4.52 M(-87.4%) | -$40.77 M(+12.5%) |
| June 2022 | - | -$36.00 M(>+9900.0%) | -$36.25 M(>+9900.0%) |
| Mar 2022 | - | -$246.00 K(-105.0%) | -$246.00 K(-99.9%) |
| Dec 2021 | $944.00 K(-135.0%) | - | - |
| Dec 2020 | -$2.70 M(-28.7%) | - | - |
| Dec 2020 | - | $4.95 M(-102.0%) | -$269.88 M(-2.6%) |
| Sept 2020 | - | -$250.35 M(>+9900.0%) | -$276.98 M(+932.9%) |
| June 2020 | - | -$1.11 M(-95.2%) | -$26.82 M(+2.7%) |
| Mar 2020 | - | -$23.37 M(+988.3%) | -$26.11 M(+590.1%) |
| Dec 2019 | -$3.78 M | - | - |
| Dec 2019 | - | -$2.15 M(+1036.0%) | -$3.78 M(-53.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$189.00 K(-53.9%) | -$8.17 M(-10.4%) |
| June 2019 | - | -$410.00 K(-60.5%) | -$9.11 M(-7.5%) |
| Mar 2019 | - | -$1.04 M(-84.1%) | -$9.85 M(-6.6%) |
| Dec 2018 | -$10.54 M(+47.0%) | - | - |
| Dec 2018 | - | -$6.53 M(+476.4%) | -$10.54 M(+33.0%) |
| Sept 2018 | - | -$1.13 M(-1.0%) | -$7.92 M(+13.3%) |
| June 2018 | - | -$1.14 M(-33.9%) | -$7.00 M(-3.6%) |
| Mar 2018 | - | -$1.73 M(-55.8%) | -$7.25 M(+1.2%) |
| Dec 2017 | -$7.17 M(+136.9%) | - | - |
| Dec 2017 | - | -$3.92 M(+1819.6%) | -$7.17 M(+119.0%) |
| Sept 2017 | - | -$204.00 K(-85.5%) | -$3.27 M(-46.1%) |
| June 2017 | - | -$1.40 M(-14.7%) | -$6.07 M(+30.0%) |
| Mar 2017 | - | -$1.65 M(+7733.3%) | -$4.67 M(+54.4%) |
| Dec 2016 | -$3.03 M(>+9900.0%) | - | - |
| Dec 2016 | - | -$21.00 K(-99.3%) | -$3.03 M(+0.7%) |
| Sept 2016 | - | -$3.00 M(>+9900.0%) | -$3.00 M(>+9900.0%) |
| June 2016 | - | -$4000.00(<-9900.0%) | -$4000.00(<-9900.0%) |
| Mar 2016 | - | $0.00 | $0.00 |
| Dec 2015 | -$3000.00 | - | - |
FAQ
- What is Biohaven Pharmaceutical Holding annual cash flow from investing activities?
- What is the all time high annual CFI for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding annual CFI year-on-year change?
- What is Biohaven Pharmaceutical Holding quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding quarterly CFI year-on-year change?
- What is Biohaven Pharmaceutical Holding TTM cash flow from investing activities?
- What is the all time high TTM CFI for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding TTM CFI year-on-year change?
What is Biohaven Pharmaceutical Holding annual cash flow from investing activities?
The current annual CFI of BHVN is $129.83 M
What is the all time high annual CFI for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high annual cash flow from investing activities is $129.83 M
What is Biohaven Pharmaceutical Holding annual CFI year-on-year change?
Over the past year, BHVN annual cash flow from investing activities has changed by +$434.62 M (+142.60%)
What is Biohaven Pharmaceutical Holding quarterly cash flow from investing activities?
The current quarterly CFI of BHVN is -$93.40 M
What is the all time high quarterly CFI for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high quarterly cash flow from investing activities is $76.25 M
What is Biohaven Pharmaceutical Holding quarterly CFI year-on-year change?
Over the past year, BHVN quarterly cash flow from investing activities has changed by -$151.95 M (-259.52%)
What is Biohaven Pharmaceutical Holding TTM cash flow from investing activities?
The current TTM CFI of BHVN is -$161.21 M
What is the all time high TTM CFI for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high TTM cash flow from investing activities is $164.92 M
What is Biohaven Pharmaceutical Holding TTM CFI year-on-year change?
Over the past year, BHVN TTM cash flow from investing activities has changed by -$30.94 M (-23.75%)